GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » DaVita Inc (NYSE:DVA) » Definitions » Median PS Value

DaVita (DaVita) Median PS Value

: $142.09 (As of Today)
View and export this data going back to 1995. Start your Free Trial

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. DaVita's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $130.278. DaVita's 10-Year median PS Ratio is 1.0907. Therefore, the Median PS Value for today is $142.09.

As of today (2024-04-18), DaVita's share price is $126.66. DaVita's Median PS Value is $142.09. Therefore, DaVita's Price to Median PS Value for today is 0.89.

The historical rank and industry rank for DaVita's Median PS Value or its related term are showing as below:

DVA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.53   Med: 0.86   Max: 1.25
Current: 0.89

During the past 13 years, the highest Price to Median PS Value of DaVita was 1.25. The lowest was 0.53. And the median was 0.86.

DVA's Price-to-Median-PS-Value is ranked worse than
61.3% of 230 companies
in the Healthcare Providers & Services industry
Industry Median: 0.74 vs DVA: 0.89

DaVita Median PS Value Historical Data

The historical data trend for DaVita's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaVita Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Median PS Value
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 90.91 114.66 128.18 140.13 142.09

DaVita Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Median PS Value Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 140.13 142.58 142.68 142.23 142.09

Competitive Comparison

For the Medical Care Facilities subindustry, DaVita's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita Price-to-Median-PS-Value Distribution

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where DaVita's Price-to-Median-PS-Value falls into.



DaVita Median PS Value Calculation

DaVita's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=130.278*1.0907
=142.09

10-Year Median PS Ratio is 1.0907.
DaVita's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $130.278.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DaVita  (NYSE:DVA) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

DaVita's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=126.66/142.09
=0.89

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DaVita Median PS Value Related Terms

Thank you for viewing the detailed overview of DaVita's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


DaVita (DaVita) Business Description

Traded in Other Exchanges
Address
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Executives
Christopher Michael Berry officer: Chief Accounting Officer C/O SONDER HOLDINGS INC., 101 15TH ST., SAN FRANCISCO CA 94103
Kathleen Alyce Waters officer: Chief Legal Officer C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202
Wendy Lee Schoppert director 6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442
Phyllis R Yale director
Javier Rodriguez officer: Chief Executive Officer, DKC 601 HAWAII ST., EL SEGUNDO CA 90245
Barbara J Desoer director CITIGROUP INC., 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10013
James O Hearty officer: Chief Compliance Officer 2000 16TH STREET, DENVER CO 80202
Charles Berg director, officer: Executive Chair, DMG 48 MONROE TURNPIKE, TRUMBULL CT 06611
John M Nehra director 1119 ST PAUL ST, BALTIMORE MD 21202
Adam H Schechter director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Michael David Staffieri officer: Chief Operating Officer, DKC 2000 16TH STREET, DENVER CO 80202
Jason M. Hollar director 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Paula A Price director ONE CVS DRIVE, WOONSOCKET RI 02895
Pamela M Arway director 601 HAWAII ST., EL SEGUNDO CA 90245
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601

DaVita (DaVita) Headlines

From GuruFocus

Q2 2023 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2022 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2021 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2020 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2022 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q1 2019 DaVita Inc Earnings Call Transcript

By GuruFocus Research 01-22-2024